Article Sidebar

Submitted
Apr 24, 2021
Published
Apr 24, 2021
Download
PDF
Statistic
Read Counter : 52 Download : 40

Main Article Content

Abstract

Migraine is the most common neurological condition in the world affecting about 1 in 10 people. It is 3 times more common in women. Several studies suggest an association of migraine with the body mass index, blood group and comorbidities. The aim of this study is to determine a possible relationship between the prevalence, symptoms, triggers and comorbidities of migraine as well as its association with obesity and blood group.


Design


A prospective observational study


Subject and Methods


A total of 204 patients with migraine were included whose age ranged between 18 to 65 years of both gender. The prevalence of migraine and its relation to body mass index and blood group were analyzed.


Results


The study included 83.82% females and 16.18% males. 36.6% of the included patients have a normal body weight and the study concluded that majority (90%) have O positive blood group.  Symptoms are experienced mostly during the attack stage and the major trigger was emotional stress affecting 53% of study population.


Conclusion


Prevalence of migraine is high among females. Younger age and female sex are other contributory factors as prevalence of migraine. Emotional stress is mediating as the major trigger of migraine and excluding the normal eight subjects, pre-obese patients have higher risk for migraine. The co-morbidities didn’t suggest any apparent relation with migraine, though hypothyroidism was observed in a few populations.

Keywords

Migraine Prevalence Body Mass Index Symptoms Triggers Comorbidities

Article Details

How to Cite
Kirsha K S, C I Sajeeth, Sona Mohandas, Sharafudheen PK, Prasanth Parameswaran, Bijiraj V, & Mohammad Mazharudheen. (2021). Migraine: prevalence, body mass index, blood group and comorbidities; a prospective observational study. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(3), 255-261. https://doi.org/10.61096/ijrpp.v6.iss3.2017.255-261
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Headache classification committee of the international headache s. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia.33, 2013, 629–808
  2. [2]. The world health report 2001: mental health: new understanding, new hope. Geneva: world health organization; 2001.
  3. [3]. Kartavya Sharma et al. Quality of life and psychiatric co‑morbidity in Indian migraine patients: A headache clinic sample, Neurology India | 61(4), 2013.
  4. [4]. Kulkarni et al. Headache disorders and public ill-health in India: prevalence estimates in Karnataka State; The Journal of Headache and Pain 16, 2015, 67; DOI 10.1186/s10194-015-0549-x
  5. [5]. Ornello et al. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies; The Journal of Headache and Pain 16, 2015, 27
  6. [6]. Chai et al. Obesity and Headache: Part I – A Systematic Review of the Epidemiology of Obesity and Headache; Headache. 54(2), 2014, 219–234. doi:10.1111/head.12296.
  7. [7]. Nishi K et al. Study on the Incidence of Hypertension and Migraine in ABO Blood Groups; ISCA J. Biological Sci. 1(2), 2012, 12-16.
  8. [8]. Rao GN et al. The burden of headache disorders in India: methodology and questionnaire validation for a community‑based survey in Karnataka state. J headache pain 13, 2012, 543‑50
  9. [9]. Aamodt AH et al. Comorbidity of headache and gastrointestinal complaints. The head-hunt study. Cephalalgia 28, 2008, 144-151.
  10. [10]. Yadav et al. A Study of Triggers of Migraine in India; Pain Medicine 11, 2010, 44–47
  11. [11]. Gowri et al., Prevalence and impact of primary headache disorders among students and working population in 18-25 years age group; Int J Med Res Health Sci. 3(2), 2014, 416-419
  12. [12]. Sanjeev K. Bhoi et al. Metabolic syndrome and insulin resistance in migraine; J Headache Pain 13, 2012, 321–326; DOI 10.1007/s10194-012-0416-y
  13. [13]. Rosario D et al. Role of Gender and Serum Immunoglobulin E (IGE) levels; Journal of Clinical and Diagnostic Research. 8(2), 2014, 57-58
  14. [14]. Bigal E et al. Obesity and migraine: a population study. Neurology 66, 2006, 545–550
  15. [15]. Mayo Clinic Staff. Mayo Clinic Guide to Pain Relief. http://www.mayoclinic.com/health/ migraine headache/DS00120/D section=causes
  16. [16]. Rist et al. Associations Between Lipid Levels and Migraine: Crosssectional Analysis in the EVA Study; Cephalalgia . 31(14), 2011, 1459–1465. doi:10.1177/0333102411421682.
  17. [17]. Grebe HP etal.Role of arterial hypertension in comorbidity of chronic headaches. Rev Neurol 33(2), 2001, 119-122.
  18. [18]. Cook NR et al. Migraine and coronary heart disease in women and men. Headache. 42(8), 2002, 715–27. Epub 2002/10/23. eng.
  19. [19]. Jarman J et al. High incidence of endogenous depression in migraine: Confirmation by tyramine test. J NeurolNeurosurg Psychiatry 53, 1990, 573‑5.
  20. [20]. Hagen K et al. Low headache prevalence amongst women with high TSH values. Eur J Neurol. 8(6), 2001, 693-9.